NCT04255602

A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients

A Randomized Non-inferiority Study of Low-dose and Standard-dose Ticagrelor After Intervention for Acute Coronary Syndrome

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 2,120 (estimated)
• Sponsor: Shanghai Tong Ren Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

This study is to evaluate the safety and efficacy of 60mg ticagrelor plus 100mg Aspirin to prevent major adverse cardiovascular and cerebrovascular events in one years after drug-eluting stents implantation for Chinese ACS patients compared with 90mg ticagrelor plus 100mg Aspirin

Conditions

• Acute Coronary Syndrome
• Coronary Stent Implantation

Interventions

Type	Name	Description
DRUG	Ticagrelor 60mg	Ticagrelor 60mg plus Aspirin 100mg for experimental group
DRUG	Ticagrelor 90mg	Ticagrelor 90mg plus Aspirin 100mg for active comparator group

Timeline

• Start date: 2020-02-19
• Primary completion: 2024-12-31
• Completion: 2024-12-31
• First posted: 2020-02-05
• Last updated: 2023-12-07

Locations

8 sites across 1 country: China